Hodges Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-2,620
Closed -$297K – 225
2024
Q2
$297K Buy
2,620
+120
+5% +$15.2K 0.02% 194
2024
Q1
$347K Buy
+2,500
New +$314K 0.02% 192
2022
Q3
– Sell
-6,072
Closed -$452K – 208
2022
Q2
$452K Hold
6,072
– – 0.05% 172
2022
Q1
$776K Sell
6,072
-400
-6% -$43.8K 0.06% 162
2021
Q4
$868K Buy
6,472
+72
+1% +$10.3K 0.06% 158
2021
Q3
$874K Buy
6,400
+3,100
+94% +$391K 0.06% 158
2021
Q2
$352K Hold
3,300
– – 0.04% 196
2021
Q1
$296K Buy
+3,300
New +$310K 0.04% 189
2020
Q2
– Sell
-3,632
Closed -$244K – 199
2020
Q1
$244K Sell
3,632
-7,808
-68% -$486K 0.06% 151
2019
Q4
$626K Sell
11,440
-3,480
-23% -$165K 0.08% 138
2019
Q3
$557K Sell
14,920
-4,660
-24% -$181K 0.06% 142
2019
Q2
$733K Buy
19,580
+6,060
+45% +$190K 0.08% 130
2019
Q1
$403K Buy
+13,520
New +$475K 0.04% 183

Other funds holding DXCM

Hodges Capital Management's DXCM Position: Q3 2024 in Review

Hodges Capital Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,620 shares — an estimated $297K sold.

Hodges Capital Management first reported a position in DXCM in Q1 2019 and held it in 13 quarters. The position peaked at $874K in Q3 2021. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Hodges Capital Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Hodges Capital Management sold 2,620 DexCom shares in Q3 2024, an estimated $297K.
  • Hodges Capital Management first reported a position in DexCom in Q1 2019 and held it in 13 quarters.
  • Hodges Capital Management's DexCom position peaked at $874K in Q3 2021.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Hodges Capital Management's 13F filing for Q3 2024, filed 15 Nov 2024.